Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

NCT05503134 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: Universal Donor Natural Killer Cells

Sponsor

Nationwide Children's Hospital